Table 2.
Clinical presentation and treatment
| Variable | Value |
|---|---|
| Symptoms | |
| Cough | 16 (76.2) |
| Rhinitis | 14 (66.7) |
| Fever | 14 (66.7) |
| Dyspnea | 18 (85.7) |
| Myalgia/fatigue | 16 (76.2) |
| Diarrhea | 6 (28.6) |
| Pain | 5 (23.8) |
| Anosmia or loss of taste | 1 (4.8) |
| Findings | |
| Reduced LVEF | 0 (0.0) |
| Reduced right ventricular function | 6 (28.6) |
| Increased systolic PAP | 6 (28.6) |
| Newly diagnosed moderate to severe or severe tricuspid regurgitation | 4 (19.0) |
| New-onset arrhythmias | 4 (19.0) |
| New-onset atrial fibrillation | 2 (9.5) |
| New-onset ventricular tachycardia | 2 (9.5) |
| New thromboembolic events | 4 (19.0) |
| New deep vein thrombosis | 2 (9.5) |
| New pulmonary embolism | 2 (9.5) |
| Abnormal chest CT | 16 (76.2) |
| Treatment | |
| Piperacillin/tazobactam | 12 (57.1) |
| Meropenem | 9 (42.9) |
| Azithromycin | 4 (19.0) |
| Caspofungin | 4 (19.0) |
| Hydroxychloroquine | 3 (14.3) |
| Pausing of mycophenolate mofetil | 11 (52.4) |
| Switch from sirolimus to tacrolimus | 1 (4.8) |
| Oxygen supply | 18 (85.7) |
| Non-invasive ventilation | 8 (38.1) |
| Invasive mechanical ventilation | 8 (38.1) |
| New-onset dialysis | 5 (23.8) |
| ECLS | 3 (14.3) |
Values are presented as number and percentage
LVEF left ventricular ejection fraction, PAP pulmonary artery pressure, CT computed tomography, ECLS extracorporeal life support